Add to ORKGCopyright © 2014 Wenjun Ji et al.This is an open access article distributed under theCreativeCommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Liraglutide (a glucagon-like peptide 1 analog) was used for the treatment of type 2 diabetes (T2DM) which could produce glucose-dependent insulin secretion. Aim. The aim was to investigate whether liraglutide could improve myofibril and mitochondria injury in skeletal muscle and the mechanisms in diabetic KKAy mice.Method. We divided the male KKAy mice into 2 groups: liraglutide group (25
Abstract: The current study evaluated the glucose-lowering effect of ganoderma lucidum polysaccharid...
Liraglutide is the glucagon-like peptide-1 receptor agonist widely used for the treatment of type 2 ...
Activation of TGR5 via bile acids or bile acid analogs leads to the release of glucagon-like peptide...
The incretin effect is essential for glucose homeostasis. Glucagon-like peptide 1 (GLP-1) based drug...
Copyright © 2013 Jieyu Liu et al.This is an open access article distributed under the Creative Commo...
Copyright © 2013 K. Nonogaki and M. Suzuki. This is an open access article distributed under the Cre...
This study was to investigate the role and mechanism of liraglutide in the treatment of diabetic nep...
Copyright © 2014 Chun-Ching Shih et al. This is an open access article distributed under the Creativ...
Glucagon-like peptide-1 (GLP-1) is an incretinhormone physiologically playing a role in glucosehomeo...
Social isolation contributes to the development of obesity and insulin-independent diabetes in KKAy ...
There is a potential therapeutic application targeting brown adipose tissue (BAT). Either voluntary ...
Starting off with a structure derived from the natural compound multiflorine, a derivatisation progr...
The aim of this study was to examine the effects of chlorogenic acid (CGA) on glucose and lipid meta...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Type 2 diabetes mellitus is a major health problem and a societal burden. Individuals with prediabet...
Abstract: The current study evaluated the glucose-lowering effect of ganoderma lucidum polysaccharid...
Liraglutide is the glucagon-like peptide-1 receptor agonist widely used for the treatment of type 2 ...
Activation of TGR5 via bile acids or bile acid analogs leads to the release of glucagon-like peptide...
The incretin effect is essential for glucose homeostasis. Glucagon-like peptide 1 (GLP-1) based drug...
Copyright © 2013 Jieyu Liu et al.This is an open access article distributed under the Creative Commo...
Copyright © 2013 K. Nonogaki and M. Suzuki. This is an open access article distributed under the Cre...
This study was to investigate the role and mechanism of liraglutide in the treatment of diabetic nep...
Copyright © 2014 Chun-Ching Shih et al. This is an open access article distributed under the Creativ...
Glucagon-like peptide-1 (GLP-1) is an incretinhormone physiologically playing a role in glucosehomeo...
Social isolation contributes to the development of obesity and insulin-independent diabetes in KKAy ...
There is a potential therapeutic application targeting brown adipose tissue (BAT). Either voluntary ...
Starting off with a structure derived from the natural compound multiflorine, a derivatisation progr...
The aim of this study was to examine the effects of chlorogenic acid (CGA) on glucose and lipid meta...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Type 2 diabetes mellitus is a major health problem and a societal burden. Individuals with prediabet...
Abstract: The current study evaluated the glucose-lowering effect of ganoderma lucidum polysaccharid...
Liraglutide is the glucagon-like peptide-1 receptor agonist widely used for the treatment of type 2 ...
Activation of TGR5 via bile acids or bile acid analogs leads to the release of glucagon-like peptide...